Checkpoint Therapeutics Stock Technical Analysis
| CKPT Stock | USD 4.39 0.11 2.57% |
As of the 1st of December, Checkpoint Therapeutics shows the mean deviation of 3.2, and Risk Adjusted Performance of 0.2196. Checkpoint Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Checkpoint Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Checkpoint, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CheckpointCheckpoint |
Checkpoint Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 23.4 | Strong Buy | 3 | Odds |
Most Checkpoint analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Checkpoint stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Checkpoint Therapeutics, talking to its executives and customers, or listening to Checkpoint conference calls.
Checkpoint Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Checkpoint Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Checkpoint Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Checkpoint Therapeutics Trend Analysis
Use this graph to draw trend lines for Checkpoint Therapeutics. You can use it to identify possible trend reversals for Checkpoint Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Checkpoint Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Checkpoint Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Checkpoint Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.04 , which means Checkpoint Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 46.46, which is the sum of squared deviations for the predicted Checkpoint Therapeutics price change compared to its average price change.About Checkpoint Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Checkpoint Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Checkpoint Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Checkpoint Therapeutics price pattern first instead of the macroeconomic environment surrounding Checkpoint Therapeutics. By analyzing Checkpoint Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Checkpoint Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Checkpoint Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2023 (projected) | Payables Turnover | 3.0 | 6.63 | Days Of Inventory On Hand | 7.0E-6 | 8.0E-6 |
Checkpoint Therapeutics December 1, 2024 Technical Indicators
Most technical analysis of Checkpoint help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Checkpoint from various momentum indicators to cycle indicators. When you analyze Checkpoint charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2196 | |||
| Market Risk Adjusted Performance | 3.52 | |||
| Mean Deviation | 3.2 | |||
| Semi Deviation | 3.09 | |||
| Downside Deviation | 3.76 | |||
| Coefficient Of Variation | 361.37 | |||
| Standard Deviation | 4.04 | |||
| Variance | 16.33 | |||
| Information Ratio | 0.2427 | |||
| Jensen Alpha | 1.07 | |||
| Total Risk Alpha | 0.4337 | |||
| Sortino Ratio | 0.261 | |||
| Treynor Ratio | 3.51 | |||
| Maximum Drawdown | 19.17 | |||
| Value At Risk | (5.73) | |||
| Potential Upside | 7.91 | |||
| Downside Variance | 14.12 | |||
| Semi Variance | 9.53 | |||
| Expected Short fall | (3.75) | |||
| Skewness | (0.08) | |||
| Kurtosis | (0.22) |
Additional Tools for Checkpoint Stock Analysis
When running Checkpoint Therapeutics' price analysis, check to measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.